We tested whether the opioid antagonist naloxone affects responses to plasma volume expansion (PVE) in conscious rabbits. Under basal conditions, naloxone (6 mg x kg-(1) plus 0.3 mg x kg(-1) x min(-1) i.v.) had no observable effect, except to slightly reduce heart rate. During vehicle treatment, PVE (Haemaccel; 1 ml x kg(-1) min(-1) for 30 min plus 0.2 ml x kg(-1) x min(-1) for 60 min i.v.) reduced haematocrit by 7.1+/-0.8% (from 34.8+/-1.1%), and increased central venous pressure by 3.0+/-0.9 mmHg (from -2.8+/-1.5 mmHg), cardiac output by 42+/-9 ml min(-1) x kg(-1) (from 152+/-17 ml x min(-1) x kg(-1)), systemic vascular conductance by 0.49+/-0.11 ml x min(-1) x mmHg(-1) kg(-1) (from 1.58+/-0.23 ml x min(-1) x mmHg(-1) x kg(-1)), urine flow by 0.13+/-0.04 ml x kg(-)x min(-1) (from 0.12+/-0.02 ml kg(-1) x min(-1)) and sodium excretion by 21+/-5 micromol x kg(-1) min(-1) (from 5+/-2 micromol x kg(-1) x min(-1)). During naloxone treatment, the PVE-induced changes in haematocrit and central venous pressure were similar to those during vehicle treatment, but the increases in cardiac output (24+/-7 ml kg(-1) min(-1)), systemic vascular conductance (0.25+/-0.05 ml min(-1) x kg(-1) x mmHg(-1)), urine flow (0.09+/-0.03 ml x kg(-1) min(-1)) and sodium excretion (11+/-4 micromol x kg(-1) x min(-1)) were 31-49% less. These observations indicate that endogenous opioids mediate some of the circulatory and renal excretory responses to PVE in conscious rabbits.